United States · FDA National Drug Code directory
Xofluza
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50242-583_c2da90f4-a11c-46d2-be18-53d286b084cf
- Product NDC
- 50242-583
- Form
- GRANULE, FOR SOLUTION
- Composition / generic term
- BALOXAVIR MARBOXIL
- Labeler
- Genentech, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181024
- Source listing expiry
- 20261231
Source-listed ingredients
- BALOXAVIR MARBOXIL — 40 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (50242-583-01) / 20 mL in 1 BOTTLE, GLASS · 50242-583-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →